Buy cjc-1295 no-dac Mod grf 1-29 Online
Buy cjc-1295 no-dac Mod grf 1-29 and unlock premium research-grade quality with our CJC-1295 No DAC & Mod GRF 1-29 blend, a carefully formulated combination designed for advanced laboratory and scientific research applications. This synergistic pairing of peptides is widely studied for its role in growth hormone releasing mechanisms, offering researchers a reliable tool for investigating endocrine signaling pathways and receptor interactions.
Our formulation emphasizes high purity, precise sequencing, and consistent batch quality, ensuring dependable results across experimental settings. CJC-1295 No DAC is known for its extended activity profile in research contexts, while Mod GRF 1-29 (a refined fragment of growth hormone releasing hormone) is valued for its rapid and targeted receptor engagement. Together, they create a powerful research combination for in-vitro and controlled laboratory studies.
Each vial is lyophilized for stability, integrity, and long shelf life, supporting ease of storage and reconstitution in laboratory environments. Manufactured under strict quality standards, this blend is ideal for scientists seeking reproducible, high-quality peptide materials for investigative purposes.
What is CJC-1295 DAC?
CJC-1295 DAC, also known as DAC: GRF (Drug Affinity Complex: Growth Hormone-Releasing Factor), is a synthetic analogue of growth hormone-releasing hormone (GHRH). Developed by ConjuChem Biotechnologies, CJC-1295 DAC functions as a growth hormone secretagogue (GHS).
This innovative peptide is a modified version of GHRH (1-29) that offers enhanced pharmacokinetics and an extended half-life, making it more effective for stimulating growth hormone release.
Key Features of CJC-1295 DAC:
Synthetic analogue of GHRH
Improved pharmacokinetics
Extended half-life
Promotes growth hormone secretion
Overview of CJC-1295 No-DAC (Mod GRF 1-29)
CJC-1295 DAC is increasingly popular among athletes and bodybuilders for its potential benefits in muscle growth, fat loss, and overall performance enhancement.
CJC-1295 No-DAC and Mod GRF 1-29 are essentially the same compound. Specifically, it is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) designed to stimulate the pituitary gland to release growth hormone.
Key Characteristics
Mechanism of Action: Primarily, it binds to GHRH receptors, stimulating the natural, pulsatile secretion of growth hormone. In contrast, unlike CJC-1295 with DAC (which binds to albumin and stays active for days), the “no-DAC” version has a short half-life of about 30 minutes.
Purpose and Usage
Because of its short half-life, Mod GRF 1-29 is often used in scientific settings to mimic the body’s natural nighttime pulses of growth hormone without causing prolonged elevations.
Common Research Combinations
In laboratory and research studies, it is frequently combined with growth hormone secretagogues (GHS) like Ipamorelin or GHRP-6. This combination creates a synergistic release of growth hormone.
Important Safety Considerations
Regulatory Status: It is crucial to note that these substances are strictly intended for in vitro laboratory research and are not approved by regulatory bodies (like the FDA) for human consumption or therapeutic use.
Potential Side Effects:
If misused, side effects can include injection site pain, facial flushing, water retention, and potential impacts on insulin sensitivity. Thus, always consult safety data from trusted sources.
Safety Data and Verification:
For official research guidelines and safety profiles, consult resources like the U.S. Food and Drug Administration (FDA) or review comprehensive peptide documentation provided by accredited scientific suppliers like BOC Sciences. Finally, always refer to third-party Certificates of Analysis (COAs) to verify the purity and identity of any research compounds.
For research use only. Not for human or veterinary consumption.
